Ting-Ren Lu
Overview
Explore the profile of Ting-Ren Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu D, Lu T
Infect Disord Drug Targets
. 2023 Jan;
23(4):e170123212803.
PMID: 36650650
Aim: HIV infection is currently an incurable disease characterized by life-long drug utility. Its incurable causality and mechanism are still unknown to us. Methods: To overcome this therapeutic setback, some...
2.
Lu D, Lu T, Yarla N, Xu B
Rev Recent Clin Trials
. 2022 Aug;
17(4):291-299.
PMID: 35986532
Aims: Cancer is a high-mortality disease (9.6 million deaths in 2018 worldwide). Given various anticancer drugs, drug selection plays a key role in patient survival in clinical trials. Methods: Drug...
3.
Lu D, Lu T
Curr Rev Clin Exp Pharmacol
. 2021 Sep;
18(1):3-11.
PMID: 34515020
The techniques and qualities of drug sensitivity testing (DST) for anticancer treatment have grown rapidly in the past two decades worldwide. Much of DST progress came from advanced systems of...
4.
Lu D, Zhu P, Wu H, Xu B, Lu T
Cent Nerv Syst Agents Med Chem
. 2019 Jan;
19(1):15-23.
PMID: 30644350
The article entitled “Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery”, by Da-Yong Lu, Peng-
Peng Zhu, Hong-Ying Wu, Nagendra Sastry Yarla, Bin Xu, Jian Ding, Ajit Varki and...
5.
Lu D, Lu T, Wu H, Yarla N, Ding J, Xu B
Recent Pat Antiinfect Drug Discov
. 2018 Oct;
13(3):217-227.
PMID: 30362422
Background And Aims: AIDS (acquired immune deficient syndrome), a deadly human infectious disease is caused by HIV (human immunodeficiency viruses) infection. Patient's mortality was eventually reduced to one-fourth by combined...
6.
Lu D, Zhu P, Wu H, Yarla N, Xu B, Lu T
Cent Nerv Syst Agents Med Chem
. 2018 Aug;
18(3):206-212.
PMID: 30117402
Introduction: Suicide is still a major event of human mortality worldwide. Yet human suicide prediction, prevention and therapeutic systems at this moment are generally ineffective in the clinic. No diagnostic...
7.
Lu D, Wu H, Yarla N, Lu T, Xu B, Jian-Ding
Infect Disord Drug Targets
. 2018 Aug;
19(1):17-29.
PMID: 30101721
The constant Ebola epidemic outbreaks in Africa arisen in waves of panic worldwide. There is a high mortality rate (30-70%) among the Ebola-infected people in virus- stricken areas. Despite these...
8.
Lu D, Lu T, Yarla N, Wu H, Xu B, Ding J, et al.
Rev Recent Clin Trials
. 2017 Aug;
12(3):202-211.
PMID: 28782482
Aim: The modality of anticancer drug combinations needs to be renovated from empirical into technical-supportive systems. Methods: To challenge past therapeutic routines, the new landscape may be established. Among the...
9.
Lu D, Wu H, Yarla N, Xu B, Ding J, Lu T
Infect Disord Drug Targets
. 2017 May;
18(1):15-22.
PMID: 28474549
AIDS (acquired immune deficient syndrome) is a deadly human viral infectious disease caused by HIV (human immune-deficient virus) infection. Almost every AIDS patient losses his/her life before mid 1990s. AIDS...
10.
Lu D, Qu R, Lu T, Wu H
Rev Recent Clin Trials
. 2017 Feb;
12(2):101-110.
PMID: 28190390
Background: Last two to three decades, this world witnesses a rapid progress of biomarkers and bioinformatics technologies. Cancer bioinformatics is one of such important omics branches for experimental/clinical studies and...